Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Protox Therapeutics Inc T.PRX



TSX:PRX - Post by User

Protox Therapeutics Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(540)
•••
Post by cabbieJBJon Jan 25, 2010 8:34am
399 Views
Post# 16714055

Detailed Results

Detailed ResultsBioboy:

I didn't see any urine flow and prostate volume results in the NR; they were part of the prtocol. 

The NR stated:

Detailed results from this study will be presented by Professor Mostafa Elhilali during a podium session at the Annual Meeting of the American Urological Association to be held in San Francisco, May 29 - June 3, 2010.

To me that means more data is to come.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities